KMT2A and leukemia: Similar to findings in the MLL-AF9 leukemia model, we observed that Il1rl1+Foxp3+ Tregs were significantly reduced in the spleen and liver of BC281-treated mice compared to those receiving BC462 (Supplementary Fig. 27B).